Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hypoglycemia incidence and awareness among insulin-treated patients with diabetes: the HAT study in Brazil.
Lamounier RN, Geloneze B, Leite SO, Montenegro R Jr, Zajdenverg L, Fernandes M, de Oliveira Griciunas F, Ermetice MN, Chacra AR; HAT Brazil study group. Lamounier RN, et al. Among authors: geloneze b. Diabetol Metab Syndr. 2018 Nov 21;10:83. doi: 10.1186/s13098-018-0379-5. eCollection 2018. Diabetol Metab Syndr. 2018. PMID: 30479669 Free PMC article.
Postprandial hyperglycemia: treating its atherogenic potential.
Geloneze B, Lamounier RN, Coelho OR. Geloneze B, et al. Arq Bras Cardiol. 2006 Nov;87(5):660-70. doi: 10.1590/s0066-782x2006001800018. Arq Bras Cardiol. 2006. PMID: 17221045 Free article. Review. English, Portuguese. No abstract available.
Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study.
Russell-Jones D, Cuddihy RM, Hanefeld M, Kumar A, González JG, Chan M, Wolka AM, Boardman MK; DURATION-4 Study Group. Russell-Jones D, et al. Diabetes Care. 2012 Feb;35(2):252-8. doi: 10.2337/dc11-1107. Epub 2011 Dec 30. Diabetes Care. 2012. PMID: 22210563 Free PMC article. Clinical Trial.
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Nowack C, Kolkhof P, Ferreira AC, Schloemer P, Filippatos G; on behalf of the FIDELIO-DKD study investigators; FIDELIO-DKD study investigators. Bakris GL, et al. Am J Nephrol. 2019;50(5):333-344. doi: 10.1159/000503713. Epub 2019 Oct 25. Am J Nephrol. 2019. PMID: 31655812 Free PMC article. Clinical Trial.
139 results